<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002202'>Pleural effusions</z:hpo> are rarely observed in patients with <z:hpo ids='HP_0004808'>acute myelogenous leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>), <z:hpo ids='HP_0011009'>acute</z:hpo> lymphocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (ALL) and <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>)/myeloproliferative <z:hpo ids='HP_0002664'>neoplasm</z:hpo> (MPN) </plain></SENT>
<SENT sid="1" pm="."><plain>Therefore the underlying etiology of <z:hpo ids='HP_0002202'>pleural effusions</z:hpo> and the efficacy and safety of pleural procedures in this population has not been well studied </plain></SENT>
<SENT sid="2" pm="."><plain>In a retrospective review of cases from 1997 to 2007, we identified 111 patients with <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>/MPN who underwent pleural procedures </plain></SENT>
<SENT sid="3" pm="."><plain>Clinical characteristics were reviewed, and survival outcomes were estimated by Kaplan-Meier methods </plain></SENT>
<SENT sid="4" pm="."><plain>A total of 270 pleural procedures were performed in 111 patients (69 AML, 27 ALL, 15 MDS/MPN) </plain></SENT>
<SENT sid="5" pm="."><plain>The main indications for pleural procedures were possible <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> (49%) and respiratory symptoms (48%), and concomitant clinical symptoms included <z:hpo ids='HP_0001945'>fever</z:hpo> (34%), <z:hpo ids='HP_0002094'>dyspnea</z:hpo> (74%), <z:hpo ids='HP_0100749'>chest pain</z:hpo> (24%) and cough (37%) </plain></SENT>
<SENT sid="6" pm="."><plain>Most patients had active disease (61%) </plain></SENT>
<SENT sid="7" pm="."><plain>The most frequent etiology of <z:hpo ids='HP_0002202'>pleural effusions</z:hpo> was <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> (47%), followed by <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> (36%) </plain></SENT>
<SENT sid="8" pm="."><plain>Severe <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> (platelet count &lt; 20 × 10(3)/µL) was present in 43% of the procedures, yet the procedural complication rate was only 1.9% </plain></SENT>
<SENT sid="9" pm="."><plain>Multivariate analysis revealed that older age, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>/MPN and active disease status were associated with a shorter median overall survival </plain></SENT>
<SENT sid="10" pm="."><plain><z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">Infection</z:e> and malignant involvement are the most common causes of <z:hpo ids='HP_0002202'>pleural effusion</z:hpo> in patients with <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>After optimizing platelet count and <z:hpo ids='HP_0003256'>coagulopathy</z:hpo>, thoracentesis may be performed safely and with high diagnostic yield in this population </plain></SENT>
<SENT sid="12" pm="."><plain>Survival in these patients is determined by the response to treatment of the <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancy</z:e> </plain></SENT>
</text></document>